Special Issue "Epigenetics and Personalized Medicine"

A special issue of Journal of Personalized Medicine (ISSN 2075-4426).

Deadline for manuscript submissions: closed (30 May 2013)

Special Issue Editor

Guest Editor
Prof. Dr. Stephan Beck

UCL Cancer Institute, University College London, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK
Website | E-Mail
Interests: genomics; epigenomics; transcriptomics; biomarker; personalized medicine

Special Issue Information

Dear Colleagues,

Personalized Medicine promises to revolutionize future healthcare and is already successfully used for treatment of some cancers. Cancer is particularly well suited for this approach and leading the way as it is essentially a disease of the genome, resulting in many mutations and epimutations that can be used to stratify patients for personalized treatment. Although epimutations (such as altered DNA methylation) occur often more frequently than mutations, their use in Personalized Medicine is currently less well established. Driven by new technologies, however, the use of epigenetics is advancing rapidly and this special issue will highlight some of the latest developments in Epigenetics for Personalized Medicine.

Prof. Dr. Stephan Beck
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epigenome
  • epimutations
  • methylome
  • DNA methylation
  • RNA methylation
  • histone modifications
  • microRNAs
  • patient stratification
  • personalized medicine

Published Papers

This special issue is now open for submission.

Journal Contact

MDPI AG
JPM Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
E-Mail: 
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to JPM Edit a special issue Review for JPM
logo
loading...
Back to Top